Stanford University
Showing 14,001-14,050 of 37,127 Results
-
Stephanie Ibe
Research Program Coordinator NOURISH - Casual, Medicine - Primary Care and Population Health
Current Role at StanfordResearch Program Coordinator - NOURISH
-
David Iberri
Clinical Associate Professor, Medicine - Hematology
BioDr. Iberri is a hematologist who specializes in the treatment of multiple myeloma, Waldenström macroglobulinemia, and other blood and bone marrow disorders. He is actively involved in clinical research evaluating novel agents in hematologic malignancies. His research interests include the development and application of biomarkers to select patients most likely to benefit from therapy, and in the development of blood tests to reduce the need for bone marrow biopsies in myeloma disease monitoring.
-
Hirotaka Ieki
Postdoctoral Scholar, Cardiovascular Medicine
BioCardiologist in Japan.
Research interest: precision medicine in cardiovascular disease. Genomics, Exposomics. -
Irogue I Igbinosa
Assistant Professor of Obstetrics and Gynecology (Maternal Fetal Medicine & Obstretrics)
BioIrogue Igbinosa, MD, MS, is a Maternal-Fetal Medicine physician at Stanford University. Her research focus includes iron deficiency anemia in pregnancy, severe maternal morbidity and mortality, and health equity. She is a NIH Women's Reproductive Health Scholar (K12) and recently, she was also recognized as the Duan Family Faculty Scholar in Maternal-Fetal Medicine.
She graduated from the University of Houston and earned her medical degree at Baylor College of Medicine. She subsequently completed her residency in Obstetrics and Gynecology Residency at Louisiana State University School of Medicine Baton Rouge. After residency, she was an AAMC-CDC Public Health Policy Fellow able to serve in the CDC Emergency Operations Center and contribute to research for healthcare providers regarding the management of the Zika virus in pregnant persons. She completed her Maternal Fetal Medicine fellowship at Stanford in 2022.
Dr. Igbinosa is passionate about community-engaged approaches to bridge gaps in evidence-based care for birthing communities and collaborates with local and national policy committees to raise awareness for reproductive justice in maternal health. In 2023, 2he was awarded the inaugural Maternal Health Implementation Science Physician Research Scholar with AMETHIST @Penn (Achieving Maternal Empowerment and Transforming Health at University of Pennsylvania) and applies to the principles learned to many aspects of her ongoing research. Her current research endeavors include co-investigator for Stanford's PHRISM: preventing inequities in hemorrhage related severe maternal morbidity, primary investigator for NOURISH - prenatal nutrition education for community health workers and doulas, as well as several hospital quality initiative efforts to improve the screening, management, and treatment of iron deficiency anemia in pregnancy. Her motto is to listen first and serve with compassion. -
Donald Iglehart
Professor of Engineering-Economic Systems & Operations Research, Emeritus
BioDonald L. Iglehart is a John von Neumann Theory Prize recipient who has made fundamental contributions to performance analysis, optimization, and simulation of stochastic systems. Iglehart received his Bachelor’s degree in Engineering Physics from Cornell in 1956, his Master’s degree in Mathematical Statistics from Stanford University in 1959, and his PhD in the same subject from Stanford in 1961. His dissertation was supervised by Herbert E. Scarf and Samuel Karlin, and the topic was on dynamic programming and stationary analysis of inventory problems. He taught at Cornell University from 1961 to 1967 and came to Stanford in 1967, where he has been emeritus since 1999. In1976, he spent a very productive year as an Overseas Fellow at Churchill College at Cambridge University. In his capacity as a PhD advisor, he has had many notable students, including Peter Glynn, Peter Haas, Phil Heidelberger, Doug Kennedy, and Ward Whitt.
Iglehart was jointly awarded the John von Neumann Theory Prize in 2002 with Cyrus Derman, the same year he was named an inaugural Fellow of the Institute for Operations Research and the Management Sciences. He was recognized for having pioneered and developed diffusion limits and approximations for heavily congested stochastic systems. His ideas provided tractable limiting processes and readily computable approximations for complex queueing and other stochastic systems for which closed-form solutions have proved intractable. Iglehart’s original research and contributions have heavily influenced queueing theory in the years since their publication, and his papers have been cited in hundreds of publications. Some of his other work has focused on inventory and distribution problems.
Iglehart was also honored by the INFORMS Simulation Society in 2012 with its highest honor, the Lifetime Professional Achievement Award (LPAA). His foundational work in that field recognized and exploited the underlying stochastic structure of simulation as a means of producing enhanced simulation methodologies. For example, he introduced and led the development of the regenerative method for stochastic simulation output analysis, inspiring a flood of significant contributions to simulation methodology. In the late 1980s, Iglehart and Glynn incorporated such techniques as importance sampling into stochastic simulations. The LPAA also noted his ability to clearly organize and articulate deep theory in his presentations and writing, and recognized his education of Ph.D. students who have had, individually and cumulatively, a profound impact on simulation education and research. The citation for his award states that "It is no exaggeration to say that Don Iglehart’s contributions made simulation a respectable research discipline in some circles of the operations research community."
In addition to being an INFORMS Fellow, Iglehart was elected in 1999 to the National Academy of Engineering, having been selected for his contributions to queueing theory, simulation methodology, inventory control, and diffusion approximations. He was also honored in 1971 through his induction as a Fellow of the Institute of Mathematical Statistics.
*****
Historical Academic Appointments:
1961-67 School of Operations Research and Industrial Engineering, Cornell University
1967-96 Department of Operations Research, Stanford University
1996-99 Department of Engineering-Economic Systems and Operations Research, Stanford University -
Yusuke Iguchi
Affiliate, Applied Physics
Current Research and Scholarly InterestsHis research specialties are in experimental condensed matter physics, magnetic excitations in microwave region, magnetic scanning probe microscopy, multiferroics, and unconventional superconductors. Currently his interest is in the unconventional superconductors such as heavy fermion and iron based ones.
-
Matthias Ihme
Professor of Mechanical Engineering, of Photon Science and, by courtesy, of Energy Science and Engineering
BioLarge-eddy simulation and modeling of turbulent reacting flows, non-premixed flame, aeroacoustics and combustion generated noise, turbulence and fluid dynamics, numerical methods and high-order schemes.
-
Debra M. Ikeda, M.D.
Professor of Radiology (Breast Imaging), Emerita
Current Research and Scholarly InterestsMy research interests are mammography positioning, tomosynthesis (DBT) cancer detection and diagnosis, MRI, DWI, MRI-guided breast biopsy, breast cancer recurrence, tattoo/ fiducial/wire localization of axillary lymph nodes, breast cancer and FDG PET-CT imaging, artifical intelligence/deep learning, breast density, density notification legislation, abscess drainages, mammography positioning
-
Gentaro Ikeda
Instructor, Medicine - Cardiovascular Medicine
BioDr. Ikeda is a physician-scientist who develops innovative diagnostic and therapeutic modalities for patients with cardiovascular disease. Based on his clinical experience as a cardiologist, he has become aware of major clinical shortcomings, specifically in the current pharmaceutical therapies for myocardial infarction (MI) and chronic heart failure (HF). Some evidence-based drug therapies, including β-blockers, ivabradine, and renin-angiotensin-aldosterone antagonists are difficult to apply to critical patients due to adverse side effects. Drugs that have shown efficacy in basic animal experiments have failed to show significant benefits in clinical trials. To address these problems, he moved to academia to conduct translational research. During his graduate training in the Egashira Lab, he focused on drug delivery systems (DDS) that target mitochondria in animal models of MI. He obtained advanced skills in molecular biology, mitochondrial bioenergetics, and animal surgery. He realized the importance of translational research and the great potential of DDS to overcome many clinical problems. He developed nanoparticle-mediated DDS containing cyclosporine for the treatment of patients with MI. He published a first-author paper and received academic awards for his novel science. Since becoming a postdoctoral fellow in the Yang Lab, he has continued to build upon his previous training in translational research. He is currently developing an innovative therapy, namely, extracellular vesicles-mediated mitochondrial transfer for mitochondria-related diseases such as heart failure and mitochondrial disease.
-
Fumiaki Ikeno
Program Director (U.S) Japan Biodesign, Stanford Biodesign, Medicine - Med/Cardiovascular Medicine
BioProgram Director (U.S) Japan Biodesign, Stanford Biodesign
Researcher Cardiovascular Medicine, Stanford University
Faculty of Japan Reach, CARE (Center for Asian Health Research and Education) , Stanford University
Co-Director of Asia, SPARK Global, Stanford SPARK , Stanford University
Dr. Ikeno is a Researcher, Cardiovascular Medicine, Stanford University. In this role, he is responsible for pre clinical studies including GLP for medical devices and also regenerative medicines for cardiovascular diseases. Currently, he is devoting himself to the international regulatory project between Japan and the United States, also known as "Harmonization by Doing", whose focus is to collaborate with regulatory agencies such as FDA, PMDA/MHLW, academia and industries for improving the regulatory process in the 2 largest medtech markets. Dr. Ikeno also devoted himself to found Japan biodesign program which is a collaborative program with University of Tokyo, Osaka University, Tohoku University, Japan Federation Medical Device Association, Ministry of Education Japan and Stanford biodesign program. Currently, Dr. Ikeno serves as the Program Director (US) for Japan Biodesign. Dr. Ikeno is co-founder and board member of US-Japan MedTech Frontier which is a non-profit cooperate to make a trans-pacific eco-system of medical device between Japan and USA.
After 9 years clinical practice as an interventional cardiologist and Family Doctor in rural areas of Japan, Dr. Ikeno came to Stanford as a Researcher and completed his Biodesign Certificate Program. Being part of the ecosystem in Silicon Valley, Dr. Ikeno participated in more than 200 medtech projects and 50 GLP studies as well as in the analysis of clinical trials for cardiovascular medicine (BARI2D, FAME, ReOPEN etc). His other academic consortium projects include Peripheral Academic Research Consortium, Global Consensus Working Group of Optical Coherence Tomography, and Japan-US consensus document for the treatment of critical limb ischemia.
Over the last decade, Dr. Ikeno has served as an advisor for medical device industries and currently serves as a chief medical officer of an incubation fund specific for medtech (Medventure Partners, Inc, Tokyo) as a spin-off from Innovation Network Corporation of Japan (INCJ) that is the largest government and private partnership fund in Japan. He is also serving as a chair of cardiovascular working group of APAN (Asian Pacific Advanced Network) that contributes the remote education, research activities, and tele-health using a specialized internet network. Dr.Ikeno is also serving as consulting faculty/lecturer roles in several universities in Japan including University of Tokyo, Osaka University, Tsukuba University etc. Dr. Ikeno has authored over 70 peer reviewed publications and textbooks and has been invited to lecture at international medical conferences. Dr. Ikeno is a council member of U.S.- Japan Council which is a non-profit organization by Japanese American. He is serving as a mentor for START-X MED which is an accelerating program for Stanford related entrepreneurs in medical fields.
Contact Information
Falk CVRC CV007
300 Pasteur Drive
Palo Alto, CA 94305-5406 -
Theresa Iker
Lecturer
BioTheresa Iker specializes in modern American politics, gender, and culture. She received her Ph.D. in History and minor in Feminist, Gender, and Sexuality Studies (FGSS) from Stanford University in 2023, where she now serves as the Choi-Lam H&S Lecturer in Undergraduate Teaching. She offers courses in the Department of History and the Stanford Introductory Studies Program.
-
Jennifer Ikle
Adjunct Clinical Assistant Professor, Pediatrics - Endocrinology
Current Research and Scholarly InterestsJen is interested in the genetic factors that lead to abnormal beta-cell function and insulin secretion, causing disorders such as hyperinsulinism and neonatal diabetes. Jen’s current research focus is the use of zebrafish models, combined with genetics and genomics, to understand cellular and molecular mechanisms of glucose metabolism and elucidate previously unknown players involved in the regulation of insulin secretion.
